These ten million varieties are out

Six months after the implementation of the new version of the basic drug catalogue, the amount of basic drug distribution has been greatly reduced At the end of last year, the nine-year new base drug catalogue was put into effect nationwide A total of 187 kinds of drugs were transferred into the new version of the basic drug catalogue, and 22 kinds were transferred out (17 of them were chemical drugs) The total number of varieties in the catalogue increased from 520 to 685, including 417 kinds of Western medicine and 268 kinds of Chinese patent medicine Half a year has passed since the first year of full implementation of the new base drug catalog nationwide According to the comparison of base drug distribution amount between January June 2019 and the same period of 2018 in Hubei Province, it is found that the distribution amount has declined sharply from 1.204 billion yuan in January June 2018 to 759 million yuan in the same period of 2019, down nearly 60% year on year, reaching 58.60%, as shown in the figure below: According to the data of Hubei basic drug centralized purchase platform, only basic drugs are compared, non basic drugs and low-cost drugs are not included in the comparison, the same below for reference It can be seen that after the national health and Health Commission officially released the national essential drug catalog (2018 Edition), the distribution and procurement pattern of essential drugs has changed greatly Prior to the official release of the new version of the basic drug catalogue last year, the general office of the State Council issued the opinions of the general office of the State Council on improving the national basic drug system, which clearly proposed that the catalogue should be dynamically adjusted and optimized, and that the dynamic adjustment should be carried out at least once every three years In principle, no varieties should be added in any place except for a small number of ethnic drugs that can be added in ethnic minority areas This is due to the removal of the list of essential drugs from some of the previous supplements Great changes, new base drugs before and after the implementation of the comparison of leading varieties According to the comparison of the distribution of basic drugs in Hubei Province between January June 2018 and January June 2019, it is found that the top 20 drugs in the distribution amount in January June 2018 are all over 10 million yuan, with a total distribution amount of more than 447 million yuan, and only 12 drugs with a total distribution amount of more than 10 million yuan in January June 2019, with a total distribution amount of 308 million yuan From the perspective of the amount of base drug distribution leading drugs, there is a big change There are only 10 drugs in the top 20 of the distribution amount in two years From January to June 2019, four new drugs were added: nifedipine sustained-release tablets (II), musk Baoxin Pills, budesonide suspension for inhalation and oseltamivir phosphate granules In addition, six drugs, such as amoxicillin capsule, were later than 20 in 2018 More than 280 supplementary base drugs have been kicked out of the catalogue According to the comparison of distribution of base drugs in two years, it is found that there are more than 280 supplementary base drugs purchased and distributed in Hubei Province from January to June 2018 (Note: for the convenience of statistics, different dosage forms are different drugs, and different concepts are different from the varieties in the catalogue of base drugs), which are not in the same period of 2019, with a total amount of 524 million yuan in half a year Among them, there are 11 drugs with more than 10 million yuan, 15 drugs with 5-10 million yuan, 29 drugs with 2-5 million yuan and 229 drugs with less than 2 million yuan 26 varieties with more than 5 million yuan have been kicked out of the new version of the list of basic drugs as follows: nearly 20 new basic drugs with more than 2 million yuan of distribution amount have been purchased from January to June 2019, reaching more than 540 new basic drugs (Note: for the convenience of statistics, different dosage forms are calculated as different drugs, which are different from the varieties in the list of basic drugs), with a total amount of 148 million yuan Among them, there are 5 drugs worth more than 5 million yuan, and 12 drugs worth between 2-5 million yuan Note: according to the basic drug purchase amount data of Hubei basic drug centralized purchase platform, for reference From the perspective of brands, 21 brands distributed more than 1 million in the newly added base drugs from January to June 2019 The details are as follows: Note: according to the data of base drug purchase amount of Hubei basic drug centralized purchase platform, it is for reference After the implementation of the new version of the basic drug catalog, the drug use structure of the grass-roots market may change Through the comparison of the above data, it is found that the "Grass-roots" situation under the abuse of infusion and antibiotics may be improved From the comparison of the top 20 drugs entering the base drug, 18 were injections in the same period of last year, while the number dropped to 11 in the same period of 2019 It can be seen that, with the enhancement of people's health awareness, the implementation of family contract doctors and the national training of grassroots doctors, the awareness of antibiotic abuse has been strengthened In addition, with the implementation of hierarchical diagnosis and treatment, many chronic diseases, such as hypertension, hyperlipidemia, diabetes and so on, after the diagnosis and confirmation of the treatment plan, most of the long-term drugs are taken from community health service stations, township hospitals and village clinics, and most of them are oral drugs For pharmaceutical enterprises, it is necessary to seize the opportunity of grass-roots medical market reform, speed up the sinking of enterprise sales channels, and seize the opportunity of grass-roots market Attachment: brands with the distribution amount of basic drugs in Hubei Province exceeding 2 million yuan from January to June 2019: Note: according to the data of Hubei Basic Drugs centralized purchase platform, only the basic drugs are counted for reference.